Source: International Congress 2016 – Clinical relevance of COPD phenotyping
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Guy Brusselle (Ghent, Belgium). Cell and molecular phenotypes of COPD. International Congress 2016 – Clinical relevance of COPD phenotyping

Member's Comments

No comment yet.

Related content which might interest you: Involvement of ferroptosis in COPD pathogenesis Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Telomere length in chronic obstructive pulmonary disease Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Myofibroblast expression in airways and alveoli is affected by smoking and COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Crosstalk between epithelium and fibroblasts; implications for COPD Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 Up-regulation of EGFR gene family in COPD patients: Correlation with airway obstruction Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Neutrophil numbers are decreased in bronchial biopsies from patients with COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 The key role of microRNA-34a in the reduction of sirtuin-1 in COPD Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by cytotoxic/ pro-inflammatory lymphocytes Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence Year: 2014 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes Source: International Congress 2016 – Mechanisms of disease Year: 2016 TGFβ-induced epithelial to mesenchymal transition (EMT) as a model of COPD Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 The identification of distinct immunophenotypical subgroups in a COPD patient population based on predominating T-lymphocyte subsets Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Genes, intervention and molecular mechanisms in COPD Source: Annual Congress 2007 - Physiological year in review Year: 2007 Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Validating SIK as a novel COPD target using four different human systems Source: International Congress 2014 – Translational studies in COPD Year: 2014 Cell composition of induced sputum in patients with uncontrolled asthma and its participation in the formation of cold airway hyperresponsiveness Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013